Along with our in vitro and mouse in vivo data, these results therefore demonstrate that stromal cell-derived Gal-1 directly target CRC cells to promote CIC features and disease progression through SOX9 and β-catenin (Figure 7). Here, LGALS1 is linked to colorectal carcinoma.